Newsletter

Effects of Exercise on Preventing and Treating Postnatal Depression

The Impact of Exercise on Postnatal Depression: Prevention and Treatment According to recent research, a staggering one in eight women suffer from postnatal depression, a condition that can occur following childbirth. While pregnancy and childbirth are typically associated with joy and happiness, many women experience feelings of depression after giving birth, with symptoms persisting for […]

Study Shows Amitriptyline as Effective Second-Line Treatment for Irritable Bowel Syndrome (IBS)

Rewrite text Image source: Getty Image Bank [메디칼업저버 배다현 기자] Research results have shown that amitriptyline, a tricyclic antidepressant, is effective as a second-line treatment for patients with irritable bowel syndrome (IBS). Tricyclic antidepressants were already recommended for the secondary treatment of IBS, but their use was low due to a lack of evidence for […]

Running as Effective as Antidepressants in Treating Depression and Anxiety, Reveals Dutch Research

New Research Shows Running can be an Effective Treatment for Depression Key Points: Research from the Netherlands suggests that running can relieve symptoms of depression and anxiety, making it just as effective as anti-depressant medication. The use of anti-depressants can have negative long-term health effects, prompting researchers to explore alternative treatments for depression that do […]

Family Medicine Specialist Esther Yeo Addresses Doubts About Plastic Surgery

Health Expert Denies Plastic Surgery Rumors Esther Yeo Opens Up About Cosmetic Procedures in Candid Interview In a recent interview on her YouTube channel, renowned family medicine specialist and CEO of a health functional food company, Esther Yeo, addressed the persistent rumors surrounding her alleged plastic surgery. Titled “Esther Yeo didn’t have plastic surgery,” the […]

[허가/임상] Phase 3 approval of Elaire, the first ADC treatment for ovarian cancer

Last week (May 22-26), a total of 23 items received item approval from the Ministry of Food and Drug Safety. There were 13 prescription drugs and 10 over the counter drugs. Approved items are approved for various indications, including type 2 diabetes, major depressive disorder, Parkinson’s syndrome, hyperlipidemia, macular degeneration, and retinopathy. The antidepressant ‘Nupram […]

[내몸 관리 지침서] Even our parents? 1 in 10 elderly people complained of ‘this disease’

Dementia is accompanied by various symptoms such as memory loss, cognitive/executive functioning and orientation (the ability to accurately recognize time, place, situation or environment), depression, and hallucinations. Photo = Pixa Bay [서울와이어 이재형 기자] #. Mr. A, a 65-year-old man who lives in Incheon, has lost his property several times since several months ago and […]

Regular dizziness, you could also be suffering from migraines

Professor Oh Seon-young from the Department of Neurology at Chonbuk National University Hospital Migraine prophylactic treatment, which is effective in the treatment of vestibular migraine CGRP antibody injection can prevent vestibular migraine with CGRP receptors distributed in the vestibular nerve of the inner ear – What is a vestibular migraine? In simple words, among the […]

If you’re feeling up and down…

◇ Bipolar disorder (manic depression) refers to a mental disorder where depressed or agitated moods persist. *Source = shutterstock As you live, there are times when you come across a person whose mood changes dramatically around you. In the morning, a person who appeared to be in a good mood may complain of depression at […]

Daewoong Pharmaceutical and NeuroLive signed a joint Research and Development contract for a new drug for the treatment of depression

[메디칼업저버 손형민 기자] Daewoong Pharmaceutical (CEOs Jeon Seung-ho and Lee Chang-jae) announced on the 28th that they recently signed a joint research and development contract with Neurolive for a new drug candidate for the treatment of depression. Through this agreement, Daewoong Pharmaceutical will enter the depression market by jointly developing ‘NR-0601’, a multi-target, non-narcotic oral […]